| S |
|
S6-Kinase as a Possible Target for the Angiogenic Activity of Interleukin-4
|
| Corbière C, Legrand E, Chagraoui A, Vannier JP, Vasse M |
| |
|
Safe Exclusion of Deep Vein Thrombosis (DVT) by a Normal Rapid ELISA D-Dimeer (<500 Ng/Ml) and by the Combination of a Negative Compression Ultrasonography and a D-Dimer of <1000 Ng/Ml in 1330 Consecutive Outpatients with Suspected DVT in the Primary Care Setting
|
| Michiels JJ, Berneman Z, Schroyens W, Maasland H, Trienekens PH, Hermsen JT |
| |
|
Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial
|
| Bauersachs RM, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, Harenberg J, Herchenhan E, Keller F, Kemkes-Matthes B, Schinzel H, Spannagl M, Thaler CJ |
| |
|
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism
|
| Iorio A, Guercini F, Ferrante F, Nenci GG |
| |
|
Safety and Potential Factors Associated with Use of Monteplase (Modified t-PA) in Routine Clinical Practice
|
| Dohiguchi Y, Watanabe R |
| |
|
Safety for Stroke in Appling Modified Recombinant T-PA, Monteplase, in Patients with Acute Myocardial Infarction in Japanese Real Clinical World
|
| Takayama M, Dohiguchi Y |
| |
|
Safety, Immunogenicity, and Efficacy of Recombinant Human Thrombin as a Topical Surgical Hemostat: Integrated Results for a Multi-Surgery Phase 2 Program
|
| Lockstadt H, Lawson J, Chapman W, Murphy A, Reynolds T |
| |
|
Satisfaction and Safety of Two Domiciliary Anticoagulation Services for Mobility-impaired Patients: Preliminary Trial Findings
|
| Akinwunmi F, Engová D, Duggan C, Bates I, MacCallum P |
| |
|
Screening Fibrinolytic Disorders with the Nijmegen Haemostasis Assay
|
| van Kraaij MGJ, Lap P, Loof A, Nováková IRO, Verbruggen H, van Heerde WL |
| |
|
Screening for Aspirin Responsiveness after TIA and Stroke in the Oxford Vascular Study: Comparison of Two Point of Care Platelet Function Tests with Aggregometry
|
| Harrison P, Segal H, Silver L, Blasbery K, Furtado C, Rothwell P |
| |
|
Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis
|
| Wu O, Robertson L, Twaddle S, Lowe GDO, Clark P, Walker ID, Brenkel I, Greaves M, Langhorne P, Regan L, Greer IA |
| |
|
Screening of Factor V Leiden (FVL) and Risk-Assessment of Venous Thrombosis in Non-FVL-Carriers: Comparison of Different Methods for Activated Protein C Resistance (APCR) Measurement
|
| Guerrero F, Nguyen F, Inguenaud C, Arnaud C, Sié P, Boneu B |
| |
|
Screening of Phage Displayed Random Peptide Libraries Reveals Conformational Epitopes of Inhibitors in a Haemophilia B Patient
|
| Königs C, Roland J, Kessel C, Stumpf S, Linde R, Escuriola C, Martinez I, Klarmann D, Dietrich U, Klingebiel T, Kreuz W |
| |
|
Search for Novel Genetic Risk Factors in Venous Thromboembolism: Design of a Family Study
|
| Wichers IM, El Kheir D, Meijers JCM, Reitsma PH, Rosendaal FR, Büller HR, Middeldorp S |
| |
|
Secretion of Functional Plasma Coagulation Proteins in Long-term Primary Cultures of Human Hepatocytes
|
| Biron-Andreani C, Bezat-Bouchahda C, Raulet E, Pichard-Garcia L, Schved J-F, Maurel P |
| |
|
SELDI-TOF MS: A Potential High-Throughput Tool for High-Density Lipoprotein Analysis
|
| Levels JHM, Bleijlevens B, Rezaee F, Aerts JMFG, Meijers JCMM |
| |
|
Selected Human/Porcine Point Substitutions Generated A Human FVIIIa with an Improved Stability
|
| Rodriguez MH, Weimer T, Ducasse C, Enjolras N, Hauser HP, Negrier C, Plantier JL |
| |
|
Selecting Patients for Long Term Prevention of Recurrent Venous Thromboembolism
|
|
| |
|
Selectin-Mediated Interactions among Platelets, Leukocytes, and Endothelial Cells
|
| McEver RP |
| |
|
Selective Thrombosis of Tumor Vasculature by RGD-directed Delivery of Truncated Tissue Factor (tTF)
|
| Torsten K, Ralf B, Teresa P, Federico H, Sandra R, Wolfgang EB, Rolf MM |
| |
|
Selenium Causes Decreased Rolling and Adhesion of Monocytes under Venous Flow Conditions Via Shedding of L-Selectin (CD62L)
|
| Ahrens IG, Ellwanger C, Bassler N, Bode C, Peter K |
| |
|
Self-assessment of Bleeding in Young Women – Results from a Multicenter Questionnaire
|
| Mondorf W, Mondorf C, Arlt M, Eifrig B, Kadar J, Kirchmaier C, Klamroth R, Kruppenbacher J, Loreth R, Zimmermann R |
| |
|
Self-Injection of Fondaparinux (Arixtra®) in the Prophylaxis against Venous Thromboembolism after Major Orthopedic Surgery is Well Accepted, Effective, and Safe: Data from the FLEXTRA Trial
|
| Kwong LM, Colwell CW, Turpie AGG, Davidson BL |
| |
|
Seminal Factor VIII and von Willebrand Factor: A Possible Role of the Conventional Clotting System in Human Semen?
|
| Lwaleed B, Greenfield R, Goyal A, Delves G, Royle R, Birch B, Cooper A |
| |
|
Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC)
|
| Gori AM, Gazzini A, Evangelisti L, Attanasio M, Manoni M, Laudati G, Seghi F, Cesari F, Abbate R, Gensini GF |
| |
|
Sensitivity and Specificity of a Rapid Quantitative Point of Care D-Dimer Assay (Cardiac D-dimer) in the Diagnosis of Deep Vein Thrombosis
|
| Dempfle CE, Korte W, Huisman MV, on behalf of the CARDIM Investigators |
| |
|
Sensitivity of Dilute Russell's Viper Venom Time (DRVVT) to Coagulation Factor Deficiency: Effect on Testing for Lupus Anticoagulant
|
| Plumhoff EA, Schulte SJ, Elliott MA, Nichols WL, Heit JA |
| |
|
Serologic Results in Suspected Heparin-Induced Thrombocytopenia
|
| Shelat SG, Pollak E |
| |
|
Serum Amyloid A (SAA) Induces Monocyte Tissue Factor
|
| Geczy CL, Cai H, Endoh I, Song C, Jessup W, McNeil HP |
| |
|
Serum Levels of Soluble Tissue Factor and the Risk of Future Coronary Artery Disease; The EPIC-Norfolk Prospective Population Study
|
| Keller TT, Boekholdt SM, Nagel D, te Velthuis H, Gerdes VEA, Hack CE, Levi MM, Khaw KT |
| |
|
Serum Osteoprotegerin in Young Survivors of Myocardial Infarction
|
| Vik A, Brodin E, Børvik T, Sveinbjørnsson B, Hansen JB |
| |
|
Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease
|
| Enayat MS, Guilliatt AM, Surdhar GK, Wilde JT, Keenan R, Chalmers EA, Tait RC, Strevens MJ, Williams MD, Hill FGH |
| |
|
Severe Acquired Factor XIII Deficiency Caused by an Autoantibody against the B Subunit
|
| Ajzner E, Schlammadinger A, Katona E, Kerenyi A, Udvardy M, Boda Z, Muszbek L |
| |
|
Severe Bleeding Caused by a Platelet Defect Leading to Enhanced Binding of Coagulation Factor XI (FXI) to Platelet GPIb-alpha
|
| Jurk K, Schulz A, Hönig M, Friedrich W, Kehrel BE |
| |
|
Severe Hemophilia B Due to a 6 kb Deletion Including Exon 4, Due to Non-Homologous Recombination and Associated with Dysfunctional Protein Missing the First EGF-like Domain
|
| Hsu T-C, Nakaya SM, Thompson AR |
| |
|
Severe Hemophilia in Poland – Focus on Hemophilic Arthropathy
|
| Windyga J, Stefanska E, Lopaciuk S, Juszynski A, Wozniak D, Strzelecki O, Buczma A, Letowska M |
| |
|
Severe Thrombotic Complications of Heparin-associated Thrombocytopenia and Thrombosis
|
| Boda Z, Schlammadinger A, Olah Zs |
| |
|
Shear Stress Induced Release of Von Willebrand Factor and Thrombospondin-1 in Huvec Extracellular Matrix Enhances Breast Tumour Cell Adhesion
|
| Fauvel-lafeve F, Gomes N, Legrand C |
| |
|
Shear-dependent Role for Soluble P-selectin in Regulating Neutrophil Adhesion to Platelets
|
| Woollard KJ, Dart A, Jackson S, Kling D, Chin-Dusting J |
| |
|
Shear-Induced Platelet Apoptosis
|
| Leytin V, Allen D, Mykhaylov S, Freedman J |
| |
|
Shielding of the A1-Domain by the Amino-Terminal Domain (AA764–1035) of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V
|
| Ulrichts H, Udvardy M, Vanhoorelbeke K, Lenting PJ, Pareyn I, Deckmyn H |
| |
|
Short and Long-term Prevention of Venous Thromboembolism. The Dutch Surgical Practice
|
| Truijers M, Kranendonk SE, Nurmohamed MT |
| |
|
Shortcomings of the Activated Partial Thromboplastin Time (aPTT) As a Routine Screening Test of Hemostasis
|
| Stoffman JM, Houston DS |
| |
|
Short-Course Use of Recombinant Factor VIIa in a Hemophilia Patient with Inhibitor Undergoing Cataract Surgeries
|
| Pekcelen Y, Yavuz AS, NamliGücükoglu SA |
| |
|
Shorter aPTT Values Are Associated with Increased Risk of Recurrence of Venous Thromboembolism (VTE) after Oral Anticoagulation (OA) Withdrawal
|
| Legnani C, Cini M, Cosmi B, Mattarozzi S, Guazzaloca G, Palareti G |
| |
|
Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations?
|
| Giordano P, Nigro A, Guanti G, Lenato G, Lastella P, Russo FG, Lisco P, Altavilla E, Sabbà C, De Mattia D |
| |
|
Sickle Cell Disease, Reduced Endothelial Nitric Oxide Synthetase and Total Nitric Oxidase Serum Levels, Abnormal Human Endothelin-1 Release, Vascular Endothelium Suffering and Thromboembolic Risk
|
| Musso R, Cultrera D, Meo A, Musso M, CipollaD'Arpa AS, Giustolisi R |
| |
|
Sickle-cell Trait and the Risk of Venous Thromboembolism
|
| Austin H, Key NS, Lally C, Dowling NF, Whitsett C, Hooper WC |
| |
|
Signal Transduction by Tissue Factor – An Unusual Cytokine Receptor
|
| Peppelenbosch MP, Versteeg HH, Borensztajn K, Diks S, Arnold Spek C |
| |
|
Signaling Mediated by Glycoprotein Ib-IX-V/VWF Interaction Mainly Takes Place in GEMs In Human Platelets
|
| Asazuma N, Kaneko M, Satoh K, Suzuki-Inoue K, Inoue O, Handa M, Berndt MC, Ozaki Y |
| |
|
Significance of Low-Grade Inflammation Markers and Soluble Cell Adhesion Molecules in Patients with Type 2 Diabetes Mellitus
|
| Korzh O, Pavlova E, Krasnokutskiy S |
| |
|
Significance of Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients with Essential Hypertension
|
| Korzh I, Fedotova I |
| |
|
Significance of the Transcription Factor KLF5 in Cardiovascular Remodeling
|
| Nagai R, Suzuki T, Aizawa K, Shindo T, Manabe I |
| |
|
Silencing of Plasminogen Activator Inhibitor-1 by Small Interfering RNA Increases the Expression of Tissue Plasminogen Activator
|
| Rupin A, Clavreul N, Sansilvestri-Morel P, Verbeuren TJ |
| |
|
Simultaneous and Coordinate Activation of Human Platelet PAR-1 and PAR-4 by Sub-Nanomolar Thrombin
|
| Ofosu FA, Dewar L, Song Y, Craven SJ, Freedman J, Fenton II J |
| |
|
Simvastatin Given for 3 Days Can Inhibit Thrombin Generation and Activation of Factor V, and Enhance Factor Va Inactivation in Hypercholesterolemic Patients
|
| Undas A, Celinska-Löwenhoff M, Brummel-Ziedins K, Brozek J, Szczeklik A, Mann K |
| |
|
Site-Directed Mutagenesis of the Alpha-1 Protease Inhibitor D-helix to That of Heparin Cofactor II Confers Heparin Specific Properties
|
| Rau JC, Church FC |
| |
|
Six Children with Congenital Deficiency of ADAMTS-13: Clinical Features and Treatment
|
| Scully M, Khair K, Gattens M, Purdy G, Mackie I, Liesner R |
| |
|
Six years' Experience of Regular Continuous Prophylactic Infusion of Clotting Factor Concentrates in Infants and Young Children with Severe Hemophilia A and B in Japan
|
| Taki M, Ohi C, Yamashita A |
| |
|
Slow Lysis of Porcine Blood Clots Is Caused by Resistance of Plasminogen to Activation
|
| Flight S, Masci PP, Lavin MF, Gaffney PJ |
| |
|
Slower Translocation of Platelets at High Shear Rate without Increased Calcium Signals on Type 2B Recombinant Von Willebrand Factor
|
| Baruch D, Feijge MAH, Legendre P, Heemskerk JWM |
| |
|
Small Interfering RNA Targeting Human EGR-1 Inhibits FGF-2 Expression, Vascular Smooth Muscle Cell Growth and Intimal Thickening in Human Saphenous Vein Explants
|
| Fahmy RG, Khachigian LM |
| |
|
Snake Venom Apoptotic L-Amino Acid Oxidase (LAAO) Inhibits Platelet Aggregation
|
| Siigur E, Samel M, Tõnismägi K, Trummal K, Siigur J |
| |
|
Snake Venoms and Haemostasis
|
| Lu Q, Clemetson JM, Clemetson KJ |
| |
|
Soluble CD146 in Women with Unexplained Pregnancy Loss: A New Insight. A Paired Case–Control Study
|
| Pasquier E, Bardin N, De Saint Martin L, Bohec C, Le Martelot MT, Mottier D, Dignat-George F |
| |
|
Soluble CD40L in Peripheral Artery Disease: Relationship with Disease Severity, Platelet Markers and the Effects of Angioplasty
|
| Blann AD, Tan KT, Tayebjee MH, Davagnanam I, Moss M, Lip GYH |
| |
|
Soluble Endothelial Protein C Receptor (sEPCR) Levels, A3 Haplotype of EPCR Gene and the Risk of Thrombosis in Carriers of Antithrombin (AT), Protein C (PC) and Protein S (PS) Defects
|
| Simioni P, Morboeuf O, Tognin G, Tormene D, Gavasso S, Woodhams B, Pagnan A |
| |
|
Soluble Endothelial Protein C Receptor Levels (sEPCR) and Thrombotic Manifestations in Carriers of Dysfunctional Protein C Variants
|
| Simioni P, Morboeuf O, Tognin G, Tormene D, Gavasso S, Fortuna S, Woodhams B, Pagnan A |
| |
|
Soluble P-Selectin Levels in Diabetes Mellitus Patients with Coronary Artery Disease
|
| Aref S, Sakrana M, Abdel Hafez A, Hamdy M |
| |
|
Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes
|
| Hansen HR, Sommeijer DW, van Oerle R, Hamulyak K, Rietveld V, van der Heide Y, van Zanten AP, Meesters E, Spronk HMH, ten Cate H |
| |
|
Soluble VEGF/sFlt-1 Ratio is Independent Predictor of AML Patient Outcome
|
| Aref S, El Sherbiny M, Goda T, Fouda M, Al Askalany H, Abdalla D |
| |
|
Special Hemocoagulative Examination at Invasive Meningococcal Disease
|
| [Scaron]lechtová J, Haj[scaron]manová Z, Kasal E, [Scaron]truncová V, Chytra I, [Scaron]efrna F, K[rcaron]í[zcedil]ová P |
| |
|
Specific Forms of Activated Factor XII in Citrated Plasma Increase Following Percutaneous Coronary Intervention (PCI)
|
| Pönitz V, Pritchard D, Grundt H, Mehus M, Nilsen D |
| |
|
Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury
|
| Yap CL, Mangin P, Nonne C, Goncalves I, Sturgeon SA, Yuan Y, Wright CE, Lanza F, Jackson SP |
| |
|
Spontaneous Subgaleal Hemorrhage in a Girl with Adrenaline Receptor Defect
|
| Hutspardol S, Chotisupakarn S, Aryurachai K, Soisamrong A, Ganjanakarn E |
| |
|
Sporadic Occurrence of Warfarin Resistance Secondary to a Val29Leu Mutation In The VKORC1 Protein
|
| Huff JD, Lawson HL, Harish VC, Zhang L, Owen J |
| |
|
Spurious Decrease of Inhibitor Levels in Plasma Containing rFVIIa
|
| Larouche V, Boulanger A, Lacroix S, St-Louis J, Rivard GE |
| |
|
Stability of CEPROTIN, Human Protein C Concentrate, for Use in Continuous Infusion
|
| Gritsch H, Weber A, Schoppmann A, Turecek PL |
| |
|
Stable Plasma D-dimer Concentrations after Prolonged Freezing
|
| Schutgens R, Haas F, Biesma D |
| |
|
Standardization of Assays for Plasma Fibrin-Fibrinogen Degradation Products
|
| Fukutake K, Nakayama H, Nishiwaki K, Oyo Y, Baba Y, Tanabe H, Koshihara K, Kagawa K, Amano K |
| |
|
Statin Beyond Lipid Lowering: Statins and Angiogenesis-Mediated Processes
|
| Mousa SA, O'Connor L, Mohamed S |
| |
|
Statins Confer a Direct Anti-Platelet Effect in Patients with Acute Myocardial Infarction Treated with Aspirin and Clopidrogel: Ex-vivo and in-vitro Study Results
|
| Matetzky S, Shenkman B, Fefer P, Shechter M, Lubetsky A, Savion N, Varon D, Hod H |
| |
|
Statins Do Not Interfere with the Antiplatelet Effect of Loading Dose Clopidogrel in Patients with Ischemic Heart Disease
|
| Toth-Zsamboki E, Béres BJ, Vargová K, Fischer E, Csóti E, Préda I, Kiss RG |
| |
|
Statins Prevent the Increase of Tissue Factor Activity and Microparticle Release Induced by Aggregated LDL in Human Vascular Smooth Muscle Cells
|
| Camino-López S, Llorente-Cortés V, Badimon L |
| |
|
Stellate Cells Produce ADAMTS13 in Human Liver
|
| Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, Iwamoto T, Mori T, Wanaka A, Fukui H, Fujimura Y |
| |
|
Sticky Platelet Syndrome Is a Cause of Cerebral Venous Thrombosis
|
| D’Amico E, Villaça P, Bassitt R, Dutra A, Camargo E, Massaro A, Bacheschi L, Scaff M, Chamone D |
| |
|
Stress-Induced Platelet Activation in Hyperhomocysteinemic Rats
|
| Pavlova N, Cherkasova K, Rudko I, Romanova E, Kubatiev A |
| |
|
Strong Antithrombotic Effect of the Type III Collagen-Related Octapeptide (KOGEOGPK) in the Mouse
|
| Maurice P, Pires V, Amant C, Bruel A, Sonnet P, Rochette J, Legrand C, Fauvel-Lafeve F, Bonnefoy A |
| |
|
Strong Lupus Anticoagulant (LA) Appears to Interfere with Activated Protein C Resistance Assay (APCR)
|
| Cimo M, Bai Y, Yumin S, Sarode R |
| |
|
Structural Requirements for the Inhibition of Thrombin by Protein C Inhibitor in the Absence and Presence of Heparin and Thrombomodulin
|
| Fortenberry YM, Whinna HC, Myles T, Leung LLK, Cooper ST, Church FC |
| |
|
Structural Studies of the Factor XI Dimeric Zymogen
|
| Papagrigoriou E, McEwan P, Walsh PN, Emsley J |
| |
|
Structure-activity Relationship of Arginine Derivatives and Staphylothrombin Inhibitory Activity
|
| Hijkata-Okunomiya PA, Kataoka N |
| |
|
Structure-Function Analysis of the Prostaglandin H2 Synthase-1 Peroxidase Site
|
| Anthony JC, Edelmiro M, Desmond JF, Kevin N |
| |
|
Studies on the Structure and Function of Factor XIII in vitro and in vivo
|
| Ichinose A |
| |
|
Study of Genetic Risk Factors for Cardiovascular Disease in the Iranian Population by Means of Reverse-Hybridization Teststrips
|
| Oberkanins C, Amini SH, Ghamari A, Kahrizi K, Pühringer H, Najmabadi H |
| |
|
Study of Spontaneous Production of Cytokines in Patients with Depression of Haemopoiesis During High Mountainous Adaptation.
|
| Saitgareeva L, Makimbetov E, Raimganov A |
| |
|
Study Of TFPI T-287C Polymorphism in Relation to Venous Thrombosis; Association/Functional Analyses and Characterization of TFPI Promoter
|
| Nekoo A Amini, Grant PJ, Ariens RAS, Iles DE |
| |
|
Study of the Methylenetetrahydrofolate Reductase Gene Promoter in Patients With Heterozygous C677T MTHFR Gene Polymorphism and Hyperhomocysteinemia
|
| Kovalenko TF, Sukhoverkhova AS, Patrusheva NL, Vanyusheva OV, Shilov IA, Kozlova TV, Bokarev IN, Patrushev LI |
| |
|
Study of the Prethrombotic State in Patients at High Risk of Developing Type 2 Diabetes Mellitus
|
| Domenech P, Sahun M, Arnan M, Pina E, Gomez JM |
| |
|
Study of the Role of Membrane Lipid Rafts in Estrogen Signaling in Human Platelets
|
| Reineri S, Piranda D, Mercalli V, Canobbio I, Torti M, Bertoni A, Sinigaglia F |
| |
|
Study on Hemostatic and Coagulate Variations During Orthotopic Liver Transplantation
|
| Wang X-f, Huang J, Xu G-q, Qu B, Huang X-p, Wang H-l |
| |
|
Study on Platelet-Associated Tissue Factor and Its Significance in Thrombotic Diseases
|
| Chen F, Huang X, Du J, Fu B, Xie Q, He S |
| |
|
Study on Secondary Structure and Properties of Human Gamma-Thrombin
|
| Kibirev VK, Shvachko LP, Poyarkova SA |
| |
|
Subcutaneous Concentrated Desmopressin Is Very Effective for Treatment of Menometrorrhagias in Women without Inherited or Acquired Bleeding Disorders
|
| Musso R, Cultrera D, Musso M, Cipolla N, Giustolisi R |
| |
|
Substitutions of Cysteine Residues in b3 Affect aIIbb3 Integrin Processing and Activation
|
| Mor-Cohen R, Rosenberg N, Lahav J, Seligsohn U |
| |
|
Subtherapeutic Oral Anticoagulant Therapy – Frequency and Risk Factors
|
| Rombouts EK, van der Meer FJM, Rosendaal FR |
| |
|
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma
|
| Colaizzo D, Tiscia T, Foti L, Vergura P, Sonni P, Cappucci F, Grandone E, Toni D, Margaglione M, Vecchione G, Chinni E, Santacroce R, Tomaiuolo M, Sessa F, Sarno M, Grandone E, Di Minno G, Margaglione M |
| |
|
Successful Immune Tolerance Induction in a High-Responding Factor VIII Inhibitor Hemophilia a Patient Treated with FVIII/VWF Plasma-Derived Concentrate, Fanhdi®. Cost Effectiveness Analysis
|
| Bastida E, Mitchell J, Savidge GF |
| |
|
Successful Immune Tolerisation in an Adolescent Severe Haemophilia a Patient with an Inhibitor: A Case Report
|
| Latimer M, McDonald A, Pidcock M |
| |
|
Successful Inhibitor-Elimination with Rituximab in Acquired Hemophilia A and a Patient with a Carrier Status for Hemophilia A – Two Case Reports
|
| Huth-Kühne A, Lages P, Zimmermann R |
| |
|
Successful Management of Pregnancy in a Patient with Type III Von Willebrand Disease and Platelet Storage Pool Disorder
|
| Vishnubhotla P, Blackwell S, Andersen JC |
| |
|
Successful Management of Pregnancy in Women with a History of Thrombotic Thrombocytopenic Purpura: A Role for ADAMTS 13 Monitoring
|
| Scully M, Starke R, Lee R, Mackie I, Machin S, Cohen H |
| |
|
Successful Surgical Haemostasis in Patients with von Willebrand Disease with Koate®DVI
|
| Viswabandya A, Mathews V, George B, Nair SC, Mammen JJ, Chandy M, Srivastava A |
| |
|
Successful Treatment of a High Titre Factor VIII Inhibitor with Rituximab Alone
|
| Dunkley S, Lindeman R |
| |
|
Successful Treatment of Acquired Haemophilia with FEIBA® and Retuximab®
|
| Malato A, Siragusa S, Anastasio R, Bonifacio G, Lo Coco L, Abbadessa V |
| |
|
Successful Use of Bivalirudin in the Treatment of Patients Suspected, or at Risk of, Heparin-Induced Thrombocytopenia
|
| Francis JL, Drexler A, Moroose R |
| |
|
Successful Use of FEIBA to Control Postoperative Bleeding after Use of rFVIIa
|
| Mathew P, McKinnell J, Jones JE, Halona M, Schwartz M |
| |
|
Sudden Versus Gradual Discontinuation of Oral Anticoagulation in Patients with Acute Venous Thromboembolism. A Randomized Study
|
| Prandoni P, Frulla M, Sartor D, Concolato A, Pagnan A |
| |
|
Sulfaminoheparosan Mediated Inhibition of Tissue Factor Induced Generation of Proteases as Studied by Protein Chip Array Analysis
|
| Cornelli U, Maddineni J, Florian-Kujawski M, Manoni M, Fareed J |
| |
|
Superior Inhibition of Platelet Aggregation Following a Loading Dose of CS-747 (Prasugrel, LY640315) Versus Clopidogrel: Correlation with the Pharmacokinetics of Active Metabolite Generation
|
| Payne CD, Brandt JT, Weerakkody GJ, Farid NA, Small DS, Ernest CS, Jansen M, Jakubowski JA, Naganuma H, Wiviott SD, Winters KJ |
| |
|
Superparamagnetic Iron Oxide Uptake as Imaged By Magnetic Resonance Is Mediated by the Integrin Receptor MAC-1 (CD11b/CD18) – Possible Implications on Imaging of Atherosclerotic Plaques
|
| von zur Muehlen C, von Elverfeldt D, Steitz B, Bassler N, Petri-Fink A, Hofmann H, Hennig J, Bode C, Peter K |
| |
|
Supperiority of Intermittent Pneumatic Compression of the legs over Elastic Stockings to Prevent Venous Thrombosis in Patients with Acute Intra-Cerebral Hemorrhage: A Randomized Trial
|
| Lacut K, Bressollette L, Le Gal G, Etienne E, De Tinteniac A, Renault A, Rouhart F, Garcia JF, Mottier D, Oger E |
| |
|
Supplemental Alpha-2-Antiplasmin Prevents Plasmin-Induced Hemorrhage
|
| Stewart D, Marder VJ, Kong M, Quon D, Cook SA, Jesmok G, Radtke KP, Baumbach GA |
| |
|
Supplementation with Folic Acid or Vitamin C and E in Patients with Bleeding Disorders and Hepatitis C Treated with Pegylated Interferon and Ribavirin
|
| Schulman S, Lethagen S, Holmström M |
| |
|
Surfaces of Glycoprotein VI Involved in Collagen Binding and Receptor Clustering
|
| Smethurst PA, O'Connor MN, Davies LW, Onley DJ, Joutsi-Korhonen L, Farndale RW, Ouwehand WH |
| |
|
Surgery in Children with Haemophilia complicated by Inhibitors
|
| Klukowska A, Laguna P |
| |
|
Surgery in Haemophilic Patients with Inhibitor
|
| Quintana M, Rodriguez Merchan EC, Romero J, Villar A, Jimenez V, Hernandez F |
| |
|
Surgical Procedures in Patients with Inhibitors to Factor VIII: A Case Series
|
| Kraut EH, Aledort LM, Arkin S, Stine KC, Wong W-Y |
| |
|
Survival and Thromboembolic Outcomes of Septic Jugular Vein Thrombosis (Lemierre's and Lemierre-Like Syndromes) in Children
|
| Goldenberg NA, Knapp-Clevenger R, Hays T |
| |
|
Sustained Calcium Influx in a Subpopulation of Platelets, Stimulated by PAR-1 Agonist Platelet Activation, Is Required for and Precedes the Exposure of Factor IXa Binding Sites and Factor X-Activation Complex Assembly
|
| London FS, Walsh PN |
| |
|
Sustained Factor VIII and vWF Elevation after Total Hip Arthroplasty
|
| Hoppener MR, Huijgen R, Henny ChP, Meijers JCM, Levi M |
| |
|
Sustained Platelet Adhesion and VWF String Formation in Stimulated Venules Of Adamts13-/- Mice
|
| Chauhan AK, Motto D, Lamb CB, Ginsburg D, Wagner DD |
| |
|
Swiss Atherothrombosis Survey – A Field report on the Occurrence of Symptomatic and Asymptomatic Peripheral Arterial Disease
|
| Hayoz D, Bounameaux H, Canova C |
| |
|
Syk Plays a Critical Role in Signalling Downstream of GPVI and Integrin aIIbb3, But Is not Required for Efficient G-Protein Mediated Platelet Activation
|
| Hughan SC, McCarty O, Schweighoffer E, Tybulewicz V, Watson SP |
| |
|
Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2
|
| Fuller GLJ, Hughan S, Suzuki-Inoue K, Schweighoffer E, Pearce AC, Senis Y, Eble JA, Pohlmann S, Tybulewicz VLJ, Ozaki Y, Watson SP |
| |
|
Symptomatic Venous Thromboembolism and Mortality after Hip Fracture Surgery: The ESCORTE Study
|
| Rosencher N, Vielpeau C, Emmerich J, Fagnani F, Chibedi D, Samama ChM |
| |
|
Syndrome Kasabach-Merritt and Severe Postoperative Bleeding
|
| Haj[scaron]manová Z, [Scaron]lechtová J, Cetkovský P, Salaj P, Kubácková K |
| |
|
Synergism between Functional Hemostatic Polymorphisms and Risk of Premature Myocardial Infarction
|
| Roldán V, González-Conejero R, Marín F, Pineda J, Pérez-Ceballos E, Sogorb F, del Rey ML, Vicente V, Corral J |
| |
|
Synergistic Antagonists for Hemophilia Treatment
|
| Butenas S, Orfeo T, Mann KG |
| |
|
Synergistic Association between Hypercholesterolemia and C46T Factor XII Polymorphism in the Development of Premature Myocardial Infarction
|
| Roldán V, Corral J, Marín F, Pineda J, García-Barberá N, Vicente V, González-Conejero R |
| |
|
Synergistic Effect of Melagatran on the Antiplatelet Efficacy of the Platelet GPIIb/IIIa Receptor Antagonist Eptifibatide or Abciximab in Inhibiting Collagen-induced Platelet Aggregation
|
| Mousa S |
| |
|
Synergistic Effect of the Platelet GPIIb/IIIa Receptor Antagonist Integrilin on the antithrombotic efficacy of Melagatran in human blood using Thrombelastography
|
|
| |
|
Synergistic Effects of Zinc and Calcium Ions on ADAMTS13 Proteolysis of Von Willebrand Factor and FRETS-VWF73
|
| Anderson PJ, Kokame K, Sadler JE |
| |
|
Synovial Microparticles in Arthritic Patients Support Coagulation and Inflammation
|
| Berckmans RJ, Nieuwland R, Kraan MC, Tak PP, Sturk A |
| |
|
Synovitis in a Murine Model of Human Factor VIII Deficiency: Pathology and the Molecular Basis of Disease
|
| Valentino L, Hakobyan N, Kazarian T |
| |
|
Synthetic Anti-Xa Drugs but not Fondaparinux Can Be Used for Surgical and Interventional Anticoagulation
|
| Iqbal O, Hoppensteadt D, Fareed D, Fareed J |
| |
|
Systematic Review of Risk Factors for Venous Thromboembolism in Hospitalized Medical Patients and Recommendations for Prophylaxis Implementation by a Multidisciplinary Group
|
| Rocha AT, Paiva EF, Filho CC, Maffei FH |
| |
|
Systemic Pre-Operative Haemostatic Marker Levels and Their Association with Disease Outcome from Uterine Cervix and Endometrial Cancers Within 2 years
|
| Khalil R, Stephen KCL, Choolani M, Ilancheran A |
| |
|
Systemic Prognostic Haemostatic Marker Levels for Disease Outcome within Five Years from Ovarian Cancer
|
| Stephen KCL, Khalil R, Choolani M, Ilancheran A |
| |
|
Systemic Sclerosis: Gene Expression Profiling by Microarray Technology of Endothelial Cells
|
| Giusti B, Del Rosso M, Fibbi G, Matucci-Cerinic M, Rossi L, Poggi F, Evangelisti L, Sestini I, Pepe G, Abbate R |
| |
